Dow Down 0.92% Nasdaq Down 0.83%

Dynavax Technologies Corporation (DVAX)

-NasdaqCM
1.47 Down 0.04(2.65%) 4:00PM EDT
Prev Close:1.51
Open:1.52
Bid:1.45 x 300
Ask:1.47 x 300
1y Target Est:4.50
Beta:4.03
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:1.46 - 1.55
52wk Range:1.10 - 2.14
Volume:2,505,325
Avg Vol (3m):1,453,710
Market Cap:386.43M
P/E (ttm):N/A
EPS (ttm):-0.32
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for DVAX

Comparison

Symbol% ChgMkt Cap
DVAXDown 2.65%386.43M
GSKUp 1.79%106.67B
MRKUp 0.69%160.13B
RHHBYDown 0.10%247.03B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):32.22
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.34
Quarterly EPS Est (Sep-14) :-0.09
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases, and cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback